| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 10/12/2005 | CN1682237A Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (SPM) reading |
| 10/06/2005 | WO2005056814A3 Methods and systems for analyzing and determining ligand-residue interaction |
| 10/06/2005 | WO2005047521A3 Methods of preparing nucleic acid for detection |
| 10/06/2005 | WO2005047520A3 System and methods for three dimensional molecular structural analysis |
| 10/06/2005 | WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna |
| 10/06/2005 | US20050222027 Modulation of complement to treat pain |
| 10/05/2005 | EP1581650A2 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis |
| 10/05/2005 | EP1581649A2 Binding agents which inhibit myostatin |
| 10/05/2005 | EP1581647A2 Rapid direct sequence analysis of multi-exon genes |
| 10/05/2005 | CN1678752A Analytical method for the determination of infant formula protein digestibility in vitro |
| 09/29/2005 | WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/29/2005 | US20050214771 Methods for identifying risk of breast cancer and treatments thereof |
| 09/28/2005 | EP1578994A2 Methods for identifying dna copy number changes |
| 09/28/2005 | EP1578993A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 09/28/2005 | EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions |
| 09/28/2005 | EP1578357A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 09/22/2005 | WO2005017183A3 Methylated gene biomarkers for detecting cancer |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/21/2005 | EP1577389A2 Magnetic pigment |
| 09/21/2005 | EP1576190A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 09/21/2005 | EP1576180A2 Ampk pathway components |
| 09/21/2005 | EP1576176A2 Short interfering nucleic acid hybrids and methods thereof |
| 09/21/2005 | EP1576175A2 Vascular-preferred promoters |
| 09/15/2005 | WO2005056812A3 Practical, cost-effective synthesis of ubiquinones |
| 09/15/2005 | WO2005007871A3 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 09/15/2005 | WO2004083449A3 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 09/15/2005 | US20050203333 Magnetized scleral buckle, polymerizing magnetic polymers, and other magnetic manipulations in living tissue |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/14/2005 | EP1573065A2 Methods for rapid forensic analysis of mitochondrial dna and characterizationg of mitochondrial dna heteroplasmy |
| 09/14/2005 | EP1573045A2 Heart failure gene determination and therapeutic screening |
| 09/14/2005 | EP1573043A2 A continuous-read assay for the detection of de novo hcv rna polymerase activity |
| 09/14/2005 | EP1573040A2 Methods and apparatus for screening and detecting multiple genetic mutations |
| 09/14/2005 | EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 09/14/2005 | EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 09/14/2005 | EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 09/14/2005 | EP1573009A2 Detection of small nucleic acids |
| 09/09/2005 | WO2005059156A3 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used |
| 09/09/2005 | WO2005042760A3 Systems and methods for detecting biological features |
| 09/09/2005 | WO2005024045A3 Primers for use in detecting beta-lactamases |
| 09/09/2005 | WO2004094652A3 Zinc-based screening test and kit for early diagnosis of prostate cancer |
| 09/07/2005 | EP1570090A2 A biological sample storage device and method for biological sample contamination testing |
| 09/07/2005 | EP1570085A2 Method for in vitro selection of 2'-substituted nucleic acids |
| 09/07/2005 | EP1570043A2 Device and method for in-line blood testing using biochips |
| 09/07/2005 | EP1151109B1 Fucosyl transferase gene |
| 09/01/2005 | WO2005003374A3 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES |
| 09/01/2005 | WO2004078992A3 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics |
| 09/01/2005 | WO2004063388A3 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 09/01/2005 | US20050192239 Methods for identifying risk of breast cancer and treatments thereof |
| 08/31/2005 | EP1567860A2 Methods and materials for examining pathways associated with glioblastoma progression |
| 08/25/2005 | WO2005078128A1 Method for detecting the risk of preeclampsia by analysing a dimethylarginine dimethylaminohydrolase gene |
| 08/25/2005 | WO2005040398A9 Methods for preserving nucleated mammalian cells |
| 08/25/2005 | WO2005010200A3 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
| 08/25/2005 | US20050186588 Designing primers for single step detection of biopolymer sequences |
| 08/25/2005 | US20050186217 Compositions produced using enteric pathogens and methods of use |
| 08/24/2005 | EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565572A2 Porcine polymorphisms and methods for detecting them |
| 08/24/2005 | CN1657620A Characterisation of gene function using double stranded (ds) RNA inhibition |
| 08/18/2005 | WO2005045056A3 Radioactive multiplexing analytical methods |
| 08/18/2005 | WO2005007868A3 Controlled platelet activation to monitor therapy of adp antagonists |
| 08/18/2005 | WO2005003376A3 Anthrax antigen vaccine cultures by fluorescence polarization |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/17/2005 | EP1563295A2 Molecular nephrotoxicology modeling |
| 08/17/2005 | EP1563089A2 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 08/17/2005 | EP1563072A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 08/17/2005 | EP1563067A2 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 08/17/2005 | EP1562641A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 08/17/2005 | EP1141399B1 Sequencing method using magnifying tags |
| 08/11/2005 | WO2004057014A3 Luminescent polymers and methods of use thereof |
| 08/11/2005 | WO2004011668A3 Methods and apparatus for screening and detecting multiple genetic mutations |
| 08/11/2005 | US20050176707 Compositions and methods for inducing cell dedifferentiation |
| 08/11/2005 | US20050176035 Destabilization of hybridization via DNA N-glycosylase/uridine nucleosidase, insertion of probe; kits |
| 08/11/2005 | EP1573040A3 Methods and apparatus for screening and detecting multiple genetic mutations |
| 08/10/2005 | EP1560930A2 Nucleic acid sequence detection |
| 08/04/2005 | WO2005024041A3 Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins |
| 08/04/2005 | WO2005024040A3 Target and method for inhibition of bacterial rna polymerase: minimized derivatives of peptide antibiotic mccj25 |
| 08/04/2005 | WO2005019471A3 Periostin-like factor: compositions and methods for making and using the same |
| 08/04/2005 | US20050170375 Methods for enhancing gene expression analysis |
| 08/04/2005 | US20050170373 Expression profiling using microarrays |
| 08/03/2005 | EP1558276A2 Flaviviris fusion inhibitors |
| 07/28/2005 | WO2005045062A3 Gene expression and polymorphisms associated with lung cancer |
| 07/28/2005 | WO2005040396A3 qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING |
| 07/28/2005 | WO2004050900A3 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 07/28/2005 | WO2004035806A3 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 07/28/2005 | US20050164324 Systems, methods and kits for characterizing phosphoproteomes |
| 07/28/2005 | US20050164238 Methods and compositions for the diagnosis of sepsis |
| 07/28/2005 | US20050164234 Antisense therapy; gene expression inhibition |
| 07/28/2005 | US20050164231 Probe composition for modeling prognostic outcomes for cell proliferative disorders; computer models for disease |
| 07/27/2005 | EP1556684A2 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 07/26/2005 | US6921643 Using template directed dye termination and fluorescence polarization detection to identify pine species containing restriction fragment length polymorphism associated with altered lignin composition |
| 07/21/2005 | WO2005040399A3 Methods for quantitative determination of methylation density in a dna locus |
| 07/21/2005 | WO2005030979A3 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays |
| 07/21/2005 | WO2004099436A3 Structural and cytoskeleton-associated proteins |
| 07/21/2005 | US20050158739 Using methylation status/profile of gene sequences as diagnostic tool in detection of cell proliferative disorders |
| 07/21/2005 | US20050158281 vascular permeability agents (VPAs), such as VEGF, used in conjunction with adeno-associated virus(AVV) a nucleic acid viral vectors; nucleic cid sequences encoding Igf-1( insulin like growth factor-1) and dystrophin or dystrophin-like proteins; muscular disorders |
| 07/20/2005 | EP1554399A1 Detecting the risk of cardiovascular diseases by detecting mutations in genes, including genes encoding a2b-adrenoceptor and apolipoprotein b |
| 07/20/2005 | CN1643142A Method of identifying genes controlling diferentiation |
| 07/14/2005 | WO2005047519A3 Lsamp and nore 1 down-regulation in clear cell renal cell carcinomas |
| 07/14/2005 | WO2005035779A3 Method |
| 07/14/2005 | WO2005021778A3 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil |